Patent · US Active

Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same

US8987230B2 · kind B2 · utility

1Cited by
6References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 30, 2008
Grant dateMar 24, 2015
Priority date
Expiry dateOct 29, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a composition comprising a hyaluronic acid derivative having a crosslinking group(s) and a hydrophilic polysaccharide derivative having a hydrophobic group(s), wherein the hyaluronic acid derivative having a crosslinking group(s) is prepared by crosslinkage formation reaction in hyaluronic acid or a derivative thereof having a crosslinkable group(s) in the presence of the hydrophilic polysaccharide derivative wherein the hydrophilic polysaccharide derivative may have a crosslinkable group(s).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.